Follow-The-Filings

Security

CRNX

Crinetics Pharmaceuticals In · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

8 owners 1 new 2 exits max 1.7% (Farallon Capital Manageme...)

grid → activity →
owners 8
max % 1.7%
tracked value $797M
qoq N 1 A 3 R 3 E 2

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Farallon Capital Management LLC 2026 Q1 1.7% Add +0.20 pp 8,338,098 $303M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% New 0.0% 684,108 $25M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Reduce 0.00 pp 9,135,504 $425M hist
Ken Fisher - Fisher Asset Management, LLC 2026 Q1 0.0% Add 0.00 pp 762,702 $28M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Add 0.00 pp 317,934 $12M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit 0.00 pp 49,699 $2M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Reduce 0.00 pp 62,368 $2M hist
Natixis Advisors, LLC 2026 Q1 0.0% Reduce 0.00 pp 18,458 $670 hist
Steve Cohen - Point72 Asset Management, L.P. exited 2026 Q1 last 2025 Q4 0.1% Exit -0.12 pp 2,337,034 $109M hist
Dmitry Balyasny - Balyasny Asset Management L.P. exited 2026 Q1 last 2025 Q4 0.0% Exit -0.01 pp 233,197 $11M hist

8 current · 2 exited last period · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue — — $7.7M
Gross profit * — — $6.62M
Gross margin * — — 86.0%
Net income -$214.53M -$298.41M -$465.32M
Net margin * — — -6046.2%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $574.15M $1.38B $1.05B
Total non-current assets * $61.2M $59.2M $77.92M
Total assets $635.35M $1.43B $1.13B
Total current liabilities $43.94M $59.68M $85.07M
Total non-current liabilities * $52.3M $50.1M $49.1M
Total equity $539.11M $1.32B $992.08M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$166.31M -$225.97M -$377.92M
Cash from investing -$200.41M -$574.82M $173.91M
Cash from financing $388.94M $1.01B $40.61M
Net change in cash * $22.22M $209.65M -$163.4M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders